nach oben

Erschienen in:

03.01.2022 | Epidemiology • Original Article

Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis

verfasst von: Yuzhui Hu, Lin Mai, Jingying Luo, Wensong Shi, Hui Xiang, Sijia Song, Liuyan Hong, Wenting Long, Biwen Mo, Miao Luo

Erschienen in: Sleep and Breathing | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The purpose of this study was to clarify the relationship between obstructive sleep apnea (OSA) and oxidative stress markers in blood.

Methods

We conducted a systematic literature search on databases including Pubmed and Embase for studies reporting circulating oxidative stress markers in patients with OSA and controls that were published between 1988 and June 2019. Standardized mean differences (SMDs) and 95% confidence intervals (95%CI) were calculated.

Results

Of the 2226 articles initially retrieved, 52 were included in our meta-analysis, covering a total of 12 oxidative stress markers. The concentrations of malondialdehyde (SMD = 1.18; 95%CI: 0.87, 1.49; p < 0.001), thiobarbituric acid reactive substances (SMD = 1.82; 95%CI: 0.79, 2.86; p = 0.001), advance oxidative protein products (SMD = 0.68; 95%CI: 0.14, 1.23; p = 0.014), total oxidant capacity (SMD = 1.32; 95%CI: 0.33, 2.31; p = 0.009), and asymmetric dimethylarginine (SMD = 0.32; 95%CI: 0.16, 0.47; p < 0.001) in the blood of patients with OSA were higher than those of the control group, whereas the concentrations of thiols (SMD = − 0.37; 95%CI: − 0.60, − 0.15; p = 0.001) and nitric oxide (SMD = − 2.61; 95%CI: − 4.02, − 1.21; p < 0.001) were lower than those of the control group.

Conclusions

The oxidative stress markers in the blood of patients with OSA were aberrant, indicating an imbalanced state of oxidation and antioxidation in OSA.

Paiva T, Attarian H (2014) Obstructive sleep apnea and other sleep-related syndromes[J]. Handb Clin Neurol 119:251–271. https://doi.org/10.1016/b978-0-7020-4086-3.00018-7 CrossRefPubMed

Billings KR, Maddalozzo J (2013) Complementary and integrative treatments: managing obstructive sleep apnea[J]. Otolaryngol Clin North Am 46(3):383–388. https://doi.org/10.1016/j.otc.2013.02.003 CrossRefPubMed

Arnold J, Sunilkumar M, Krishna V et al (2017) Obstructive sleep apnea[J]. J Pharm Bioallied Sci 9(Suppl 1):S26-s28. https://doi.org/10.4103/jpbs.JPBS_155_17 CrossRefPubMedPubMedCentral

Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population—a review on the epidemiology of sleep apnea[J]. J Thorac Dis 7(8):1311–1322. https://doi.org/10.3978/j.issn.2072-1439.2015.06.11 CrossRefPubMedPubMedCentral

Andaku DK, D'Almeida V, Carneiro G, et al (2015) Sleepiness, inflammation and oxidative stress markers in middle-aged males with obstructive sleep apnea without metabolic syndrome: a cross-sectional study[J]. Respir Res 16(1):3. https://doi.org/10.1186/s12931-015-0166-x

Ko CY, Hu AK, Chou D et al (2019) Analysis of oral microbiota in patients with obstructive sleep apnea-associated hypertension[J]. Hypertens Res 42(11):1692–1700. https://doi.org/10.1038/s41440-019-0260-4 CrossRefPubMedPubMedCentral

Lee SD, Ju G, Choi JA et al (2012) The association of oxidative stress with central obesity in obstructive sleep apnea[J]. Sleep Breath 16(2):511–517. https://doi.org/10.1007/s11325-011-0536-7 CrossRefPubMed

Barcelo A, Barbe F, de la Pena M et al (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment[J]. Eur Respir J 27(4):756–760. https://doi.org/10.1183/09031936.06.00067605 CrossRefPubMed

Arlouskaya Y, Sawicka A, Glowala M, et al (2019) Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) concentrations in patients with obesity and the risk of obstructive sleep apnea (OSA)[J]. J Clin Med 8(6):897. https://doi.org/10.3390/jcm8060897

10.

Zhou L, Ouyang R, Luo H et al (2018) Dysfunction of Nrf2-ARE signaling pathway: potential pathogenesis in the development of neurocognitive impairment in patients with moderate to severe obstructive sleep apnea-hypopnea syndrome[J]. Oxid Med Cell Longev 2018:3529709. https://doi.org/10.1155/2018/3529709 CrossRefPubMedPubMedCentral

11.

Ramya K, Sethu G, Dhanasekar T (2018) The role of nitric oxide in obstructive sleep apnea-induced insulin resistance[J]. Natl J Physiol Pharm Pharmacol 8(8):1135–1139. https://doi.org/10.5455/njppp.2018.8.0412015042018 CrossRef

12.

Chang YT, Lin HC, Chang WN et al (2017) Impact of inflammation and oxidative stress on carotid intima-media thickness in obstructive sleep apnea patients without metabolic syndrome[J]. J Sleep Res 26(2):151–158. https://doi.org/10.1111/jsr.12477 CrossRefPubMed

13.

An Z, Wang D, Yang G et al (2017) Role of microRNA-130a in the pathogeneses of obstructive sleep apnea hypopnea syndrome-associated pulmonary hypertension by targeting the GAX gene[J]. Medicine (Baltimore) 96(20):e6746. https://doi.org/10.1097/md.0000000000006746 CrossRef

14.

Lu CH, Lin HC, Huang CC et al (2015) Increased circulating endothelial progenitor cells and anti-oxidant capacity in obstructive sleep apnea after surgical treatment[J]. Clin Chim Acta 448:1–7. https://doi.org/10.1016/j.cca.2015.05.023 CrossRefPubMed

15.

Kicinski P, Dybala A, Zakrzewski M, et al (2015) Asymmetric dimethylarginine concentration in patients with obstructive sleep apnea[J]. Eur Respir J 46(suppl 59) PA2327. https://doi.org/10.1183/13993003.congress2015.PA2327

16.

Chen B, Zhang W, Chen Y et al (2015) Association of obstructive sleep apnea hypopnea syndrome with carotid atherosclerosis and the efficacy of continuous positive airway pressure treatment[J]. Zhonghua Yi Xue Za Zhi 95(34):2791–2795 PubMed

17.

Araujo Lda S, Fernandes JF, Klein MR et al (2015) Obstructive sleep apnea is independently associated with inflammation and insulin resistance, but not with blood pressure, plasma catecholamines, and endothelial function in obese subjects[J]. Nutrition 31(11–12):1351–1357. https://doi.org/10.1016/j.nut.2015.05.017 CrossRefPubMed

18.

Ozben S, Huseyinoglu N, Hanikoglu F et al (2014) Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea[J]. Eur J Clin Invest 44(11):1045–1052. https://doi.org/10.1111/eci.12338 CrossRefPubMed

19.

Nie X, Su L, Zhou Y et al (2014) Effects of allitridi capsules on endothelial function and clinical prognosis in coronary artery disease patients with obstructive sleep apnea hypopnea syndrome][J. Zhonghua Yi Xue Za Zhi 94(28):2184–2187 PubMed

20.

Abu Youssef HA, Elshazly MI, Rashed LA et al (2014) Thiobarbituric acid reactive substance (TBARS) a marker of oxidative stress in obstructive sleep apnea[J]. Egypt J Chest Dis Tuberc 63(1):119–124. https://doi.org/10.1016/j.ejcdt.2013.10.012 CrossRef

21.

Yardim-Akaydin S, Caliskan-Can E, Gökalp F et al (2013) Lipid peroxidation and DNA damage in apnea patients with or without metabolic syndrome[J]. Sleep Biol Rhythms 11(2):116–124. https://doi.org/10.1111/sbr.12012 CrossRef

22.

Ntalapascha M, Makris D, Kyparos A et al (2013) Oxidative stress in patients with obstructive sleep apnea syndrome[J]. Sleep Breathing 17(2):549–555. https://doi.org/10.1007/s11325-012-0718-y CrossRefPubMed

23.

Hanikoglu F, Ozdem S, Ozben T et al (2013) Serum ischemia modified albumin and oxidative stress parameters in patients with obstructive sleep apnea syndrome[J]. Biochimica Clinica 37:S365

24.

Bruno RM, Rossi L, Fabbrini M et al (2013) Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors[J]. J Hypertens 31(7):1456–1464. https://doi.org/10.1097/HJH.0b013e328360f773 CrossRefPubMed

25.

Yagihara F, Lucchesi L, D’Almeida V et al (2011) Difference in lipid peroxidation concentrations in adults and elderly patients with obstructive sleep apnea syndrome (OSAS)[J]. Sleep 34:A303

26.

Monneret D, Tamisier R, Ducros V et al (2011) The impact of obstructive sleep apnea on homocysteine and carotid remodelling in patients with metabolic syndrome[J]. Fundam Clin Pharmacol 25:49. https://doi.org/10.1111/j.1472-8206.2011.00930.x CrossRef

27.

Ye L, Ma GH, Chen L et al (2010) Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome[J]. Lung 188(6):469–474. https://doi.org/10.1007/s00408-010-9253-4 CrossRefPubMed

28.

Singh TD, Patial K, Vijayan VK et al (2009) Oxidative stress and obstructive sleep apnoea syndrome[J]. Indian J Chest Dis Allied Sci 51(4):217–224 PubMed

29.

Liu HG, Liu K, Zhou YN et al (2009) Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population[J]. Chin Med J (Engl) 122(12):1369–1374

30.

Takahashi KI, Chin K, Nakamura H et al (2008) Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure[J]. Antioxid Redox Signal 10(4):715–726. https://doi.org/10.1089/ars.2007.1949 CrossRefPubMed

31.

Noda A, Nakata S, Koike Y et al (2007) Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome[J]. Hypertens Res 30(8):669–676. https://doi.org/10.1291/hypres.30.669 CrossRefPubMed

32.

Hernandez C, Abreu J, Abreu P et al (2006) Effects of nasal positive airway pressure treatment on oxidative stress in patients with sleep apnea-hypopnea syndrome][J. Arch Bronconeumol 42(3):125–129. https://doi.org/10.1016/s1579-2129(06)60130-4 CrossRefPubMed

33.

Dikmenoglu N, Ciftci B, Ileri E et al (2006) Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome[J]. Sleep Med 7(3):255–261. https://doi.org/10.1016/j.sleep.2005.12.005 CrossRefPubMed

34.

Alzoghaibi MA, Bahammam AS (2005) Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study[J]. Sleep Breath 9(3):119–126. https://doi.org/10.1007/s11325-005-0022-1 CrossRefPubMed

35.

Ozturk L, Mansour B, Yuksel M et al (2003) Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients[J]. Clin Chim Acta 332(1–2):83–88. https://doi.org/10.1016/s0009-8981(03)00126-8 CrossRefPubMed

36.

Dinc ME, Ozdemir C, Ayan NN et al (2017) Thiol/disulfide homeostasis as a novel indicator of oxidative stress in obstructive sleep apnea patients[J]. Laryngoscope 127(7):E244-e250. https://doi.org/10.1002/lary.26444 CrossRefPubMed

37.

Tichanon P, Wilaiwan K, Sopida S et al (2016) Effect of continuous positive airway pressure on airway inflammation and oxidative stress in patients with obstructive sleep apnea[J]. Can Respir J 2016:3107324. https://doi.org/10.1155/2016/3107324 CrossRefPubMedPubMedCentral

38.

Sunnetcioglu A, Asker S, Alp HH et al (2016) Increased asymmetric dimethylarginine and ischemia-modified albumin levels in obstructive sleep apnea[J]. Respir Care 61(8):1038–1043. https://doi.org/10.4187/respcare.04472 CrossRefPubMed

39.

Sunnetcioglu A, Alp HH, Sertogullarindan B et al (2016) Evaluation of oxidative damage and antioxidant mechanisms in COPD, lung cancer, and obstructive sleep apnea syndrome[J]. Respir Care 61(2):205–211. https://doi.org/10.4187/respcare.04209 CrossRefPubMed

40.

Passali D, Corallo G, Petti A et al (2016) A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome[J]. Acta Otorhinolaryngol Ital 36(6):490–495. https://doi.org/10.14639/0392-100x-1361 CrossRefPubMedPubMedCentral

41.

Arisoy A, Ekin S, Sertogullarindan B et al (2016) The relationship among oxidative and anti-oxidative parameters and myeloperoxidase in subjects with obstructive sleep apnea syndrome[J]. Respir Care 61(2):200–204. https://doi.org/10.4187/respcare.04277 CrossRefPubMed

42.

Yuksel M, Okur HK, Pelin Z et al (2014) Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome[J]. Clinics (Sao Paulo) 69(4):247–252. https://doi.org/10.6061/clinics/2014(04)05 CrossRef

43.

Ortac Ersoy E, Firat H, Akaydin S et al (2014) Association of obstructive sleep apnea with homocystein, nitric oxide and total antioxidant capacity levels in patients with or without coronary artery disease[J]. Tuberk Toraks 62(3):207–214 CrossRefPubMed

44.

Li J, Wang L, Jiang M et al (2014) Relationship between serum homocysteine level and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome][J. Zhonghua Yi Xue Za Zhi 94(32):2510–2513 PubMed

45.

Yang XH, Liu X, Shang J et al (2013) Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome][J. Zhonghua Jie He He Hu Xi Za Zhi 36(4):274–279 PubMed

46.

Sales LV, Bruin VM, D’Almeida V et al (2013) Cognition and biomarkers of oxidative stress in obstructive sleep apnea[J]. Clinics (Sao Paulo) 68(4):449–455. https://doi.org/10.6061/clinics/2013(04)03 CrossRef

47.

Okur HK, Pelin Z, Yuksel M et al (2013) Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia[J]. Sleep Breathing 17(1):365–371. https://doi.org/10.1007/s11325-012-0703-5 CrossRefPubMed

48.

Guo Q, Wang Y, Li QY et al (2013) Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept[J]. Sleep Breath 17(1):311–316. https://doi.org/10.1007/s11325-012-0692-4 CrossRefPubMed

49.

Mancuso M, Bonanni E, LoGerfo A et al (2012) Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome[J]. Sleep Med 13(6):632–636. https://doi.org/10.1016/j.sleep.2011.10.030 CrossRefPubMed

50.

Jafari B, Mohsenin V (2012) Activation of heme oxygenase and suppression of cGMP are associated with impaired endothelial function in obstructive sleep apnea with hypertension[J]. Am J Hypertens 25(8):854–861. https://doi.org/10.1038/ajh.2012.56 CrossRefPubMed

51.

Baysal E, Taysi S, Aksoy N et al (2012) Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS)[J]. Eur Rev Med Pharmacol Sci 16(6):770–774 PubMed

52.

Vatansever E, Surmen-Gur E, Ursavas A et al (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels[J]. Sleep Breath 15(3):275–282. https://doi.org/10.1007/s11325-010-0378-8 CrossRefPubMed

53.

Tokuda F, Sando Y, Matsui H et al (2009) N epsilon-(hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea[J]. Am J Med Sci 338(2):127–133. https://doi.org/10.1097/MAJ.0b013e3181a478e5 CrossRefPubMed

54.

Cofta S, Wysocka E, Michalak S et al (2009) Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males[J]. Eur J Med Res 14(Suppl 4):49–52. https://doi.org/10.1186/2047-783x-14-s4-49 CrossRefPubMedPubMedCentral

55.

Sonka K, Fialova L, Volna J et al (2008) Advanced oxidation protein products in obstructive sleep apnea[J]. Prague Med Rep 109(2–3):159–165 PubMed

56.

Ozkan Y, Firat H, Simsek B et al (2008) Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)[J]. Sleep Breath 12(2):149–154. https://doi.org/10.1007/s11325-007-0148-4 CrossRefPubMed

57.

Christou K, Moulas AN, Pastaka C et al (2003) Antioxidant capacity in obstructive sleep apnea patients[J]. Sleep Med 4(3):225–228 CrossRefPubMed

58.

Barcelo A, Miralles C, Barbe F et al (2000) Abnormal lipid peroxidation in patients with sleep apnoea[J]. Eur Respir J 16(4):644–647. https://doi.org/10.1034/j.1399-3003.2000.16d13.x CrossRefPubMed

59.

Oyama J, Nagatomo D, Yoshioka G et al (2016) The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea[J]. J Cardiol 67(3):295–302. https://doi.org/10.1016/j.jjcc.2015.06.005 CrossRefPubMed

60.

Bozkurt H, Neyal A, Geyik S et al (2015) Investigation of the plasma nitrite levels and oxidant-antioxidant status in obstructive sleep apnea syndrome[J]. Noro Psikiyatr Ars 52(3):221–225. https://doi.org/10.5152/npa.2015.7607 CrossRefPubMedPubMedCentral

61.

Passali D, Corallo G, Yaremchuk S et al (2015) Oxidative stress in patients with obstructive sleep apnoea syndrome[J]. Acta Otorhinolaryngol Ital 35(6):420–425. https://doi.org/10.14639/0392-100x-895 CrossRefPubMedPubMedCentral

62.

Wysocka E, Cofta S, Piorunek T et al (2013) Blood antioxidant status, dysglycemia and obstructive sleep apnea[J]. Adv Exp Med Biol 756:121–129. https://doi.org/10.1007/978-94-007-4549-0_16 CrossRefPubMed

63.

Anunciato IF, Lobo RR, Coelho EB et al (2013) Big endothelin-1 and nitric oxide in hypertensive elderly patients with and without obstructive sleep apnea-hypopnea syndrome[J]. Arq Bras Cardiol 101(4):344–351. https://doi.org/10.5935/abc.20130179 CrossRefPubMedPubMedCentral

64.

Bochi GV, Torbitz VD, Cargnin LP et al (2012) Fructose-1,6-bisphosphate and N-acetylcysteine attenuate the formation of advanced oxidation protein products, a new class of inflammatory mediators, in vitro[J]. Inflammation 35(6):1786–1792. https://doi.org/10.1007/s10753-012-9498-6 CrossRefPubMed

65.

Marsche G, Frank S, Hrzenjak A et al (2009) Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo[J]. Circ Res 104(6):750–757. https://doi.org/10.1161/circresaha.108.193169 CrossRefPubMedPubMedCentral

Titel: Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis
verfasst von: Yuzhui Hu
Lin Mai
Jingying Luo
Wensong Shi
Hui Xiang
Sijia Song
Liuyan Hong
Wenting Long
Biwen Mo
Miao Luo
Publikationsdatum: 03.01.2022
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 4/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02557-z

Neu im Fachgebiet Innere Medizin

22.03.2023 | Diabetische Nephropathie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis

Abstract

Objectives

Methods

Results

Conclusions

Neu im Fachgebiet Innere Medizin

Spironolacton hilft chronisch kranken Diabetikernieren

Bei hypothalamischen Zyklusstörungen möglichst kausal behandeln

Wenn das Brustkrebsrezidiv die roten Blutkörperchen zerstört

Herzinsuffizienz: Opioide nicht wirksam gegen Atemnot!

Update Innere Medizin

Update Innere Medizin

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Effects of obstructive sleep apnea hypopnea syndrome on postoperative complications in patients who undergo off-pump coronary artery bypass grafting

Lateral pharyngoplasty vs. traditional uvulopalatopharyngoplasty for patients with OSA: systematic review and meta-analysis

Pulmonary disease and periodontal health: a meta-analysis

Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: a longitudinal retrospective study

Night-shift work, breast cancer incidence, and all-cause mortality: an updated meta-analysis of prospective cohort studies

Validation of the National Health And Nutritional Survey (NHANES) single-item self-reported sleep duration against wrist-worn accelerometer

Neu im Fachgebiet Innere Medizin

Spironolacton hilft chronisch kranken Diabetikernieren

Bei hypothalamischen Zyklusstörungen möglichst kausal behandeln

Wenn das Brustkrebsrezidiv die roten Blutkörperchen zerstört

Herzinsuffizienz: Opioide nicht wirksam gegen Atemnot!

Update Innere Medizin

Update Innere Medizin